Nathan Rice
Stock Analyst at Piper Sandler
(3.91)
# 688
Out of 4,734 analysts
50
Total ratings
53.12%
Success rate
11.26%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Maintains: Overweight | $48 → $53 | $38.67 | +35.76% | 6 | Nov 26, 2024 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $46 → $47 | $36.70 | +28.07% | 3 | Nov 1, 2024 | |
| BY Byline Bancorp | Reiterates: Overweight | $34 | $28.51 | +19.26% | 8 | Oct 29, 2024 | |
| BFC Bank First | Maintains: Neutral | $99 → $104 | $98.94 | +5.11% | 5 | Oct 17, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $52.62 | +40.63% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $106.80 | -21.35% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $224.23 | -12.14% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $12.02 | -25.12% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $419.26 | +3.75% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $283.99 | -17.95% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $62.25 | +33.33% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $18.20 | -17.58% | 1 | Dec 19, 2019 |
Merchants Bancorp
Nov 26, 2024
Maintains: Overweight
Price Target: $48 → $53
Current: $38.67
Upside: +35.76%
First Mid Bancshares
Nov 1, 2024
Maintains: Overweight
Price Target: $46 → $47
Current: $36.70
Upside: +28.07%
Byline Bancorp
Oct 29, 2024
Reiterates: Overweight
Price Target: $34
Current: $28.51
Upside: +19.26%
Bank First
Oct 17, 2024
Maintains: Neutral
Price Target: $99 → $104
Current: $98.94
Upside: +5.11%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $52.62
Upside: +40.63%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $106.80
Upside: -21.35%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $224.23
Upside: -12.14%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $12.02
Upside: -25.12%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $419.26
Upside: +3.75%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $283.99
Upside: -17.95%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $62.25
Upside: +33.33%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $18.20
Upside: -17.58%